|
C14ORF119 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.20290452546124E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.86120000417378E-08 |
| Normal-vs-Stage2 |
6.78199999493145E-08 |
| Normal-vs-Stage3 |
6.27342622294691E-12 |
| Normal-vs-Stage4 |
1.571030E-04 |
| Stage1-vs-Stage2 |
1.196420E-01 |
| Stage1-vs-Stage3 |
3.422100E-03 |
| Stage1-vs-Stage4 |
4.725600E-01 |
| Stage2-vs-Stage3 |
5.387200E-01 |
| Stage2-vs-Stage4 |
6.370000E-01 |
| Stage3-vs-Stage4 |
3.001600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.03466190749214E-12 |
| Normal-vs-AfricanAmerican |
1.755190E-03 |
| Normal-vs-Asian |
2.162400E-01 |
| Caucasian-vs-AfricanAmerican |
1.121370E-01 |
| Caucasian-vs-Asian |
7.005200E-01 |
| AfricanAmerican-vs-Asian |
8.047600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.35329541911733E-11 |
| Normal-vs-Female |
7.76840003435808E-09 |
| Male-vs-Female |
3.119600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.817600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.44249999722845E-08 |
| Normal-vs-Age(61-80Yrs) |
4.09530187539531E-11 |
| Normal-vs-Age(81-100Yrs) |
6.375300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.823400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.119400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.867200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.131600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.257200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.807600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.990000E-01 |
| Normal-vs-Grade 2 |
7.87199999630062E-08 |
| Normal-vs-Grade 3 |
3.04978264864531E-13 |
| Normal-vs-Grade 4 |
2.551100E-04 |
| Grade 1-vs-Grade 2 |
2.425000E-01 |
| Grade 1-vs-Grade 3 |
3.291800E-02 |
| Grade 1-vs-Grade 4 |
9.390100E-02 |
| Grade 2-vs-Grade 3 |
3.920400E-03 |
| Grade 2-vs-Grade 4 |
3.645000E-01 |
| Grade 3-vs-Grade 4 |
6.225200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.04840003134888E-09 |
| Normal-vs-ccB subtype |
2.46540010628848E-10 |
| ccA subtype-vs-ccB subtype |
2.490000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76900000203872E-08 |
| Normal-vs-N1 |
6.85089984742149E-10 |
| N0-vs-N1 |
2.136600E-03 |
|
|
